Essential medicines and health products

Fair pricing of medicines


WHO convenes a series of Fair Pricing Forums to enable stakeholders to discuss options for a fairer pricing system for pharmaceuticals.

At the 2019 Forum in Johannesburg, participants acknowledged difficulties in defining a price that is truly fair, but also that it is most important to think practically about what fairness means in practice and how all stakeholders can work together to achieve it. To that end, a set of technical working groups will focus on specific areas of pricing to determine what is achievable in the short- and medium-term, reporting to the next Fair Pricing Forum in 2021. These working groups will have focused terms of reference and concrete deliverables, with an established process for nomination and representation

Stakeholders are invited to provide feedback by 30 September 2019 (DEADLINE EXTENDED) on these next steps towards achieving a fair pricing system:

Fair pricing forum

The second Forum took place in Johannesburg, South Africa,
on 11-13 April 2019, co-sponsored
by the South African National Department of Health and WHO.

The first Forum took place in Amsterdam, the Netherlands, on 11 May 2017, and was co-sponsored by the Dutch Ministry of Health, Welfare and Sport and WHO.

Fair pricing Q&A


Andrew Rintoul
Innovation, Access and Use

Advisory Group Meeting

The informal WHO Advisory Group meeting on fair pricing was held on 22-24 November 2016. The meeting was held to discuss challenges in the current system of pricing medicines and provide advice to WHO on how to move forward with organizing the Fair Pricing Forum.